Evaluation of matrix metalloproteinase-2 expression in cervical carcinogenesis using tissue array and integrated optical density for immunoreactivity

Reproductive Sciences

Volumn 14, Issue 7, 2007, Pages 719-726

  Tee, Yi Torng ^a   Han, Chih Ping ^a   Ko, Jiunn Liang ^a   Chen, Gin Den ^a   Yang, Shun Fa ^a   Chen, Shiuan Chih ^a   Tsai, Horng Jyh ^a   Lin, Long Yau ^a   Wang, Po Hui ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

High grade cervical intraepithelial neoplasia; Integrated optical density; Matrix metalloproteinase 2; Squamous cell carcinoma; Tissue array

Indexed keywords

BETA ACTIN; GELATINASE A; MESSENGER RNA;

ARTICLE; BASEMENT MEMBRANE; CANCER GRADING; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TUMOR CELL; UPREGULATION; UTERINE CERVIX CARCINOGENESIS; UTERINE CERVIX CARCINOMA; BIOSYNTHESIS; BLOOD; ENZYMOLOGY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; TISSUE ARRAY ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 38449088097     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719107307537     Document Type: Article

References (35)

1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev Cancer. 2002 ; 2: 342-350.
2. Liotta L. Tumor invasion and metastases: role of the basement membrane. Am J Pathol. 1984 ; 117: 339-348.
3. Liotta L. Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 1986 ; 46: 1-7.
4. Garzetti GG, Ciavattini A., Lucarini G., Goteri G., De Nictolis M., Biagini G. Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: biologic significance and clinical implications of 72-kDa metalloproteinase immunostaining. Gynecol Oncol. 1996 ; 61: 197-203.
5. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nature Rev. 2002 ; 2: 163-176.
6. Powell WC, Matrisian L. Complex roles of matrix metalloproteinases in tumor progression. In: Günthert U, Birchmeier W, eds. Attempts to Understand Metastasis Formation I. Metastasis-Related Molecules. New York, NY: Springer ; 1996: 1-21.
7. Silletti S., Raz A. Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis. In: Günthert U, Birchmeier W, eds. Attempts to Understand Metastasis Formation I. Metastasis-Related Molecules. New York, NY: Springer ; 1996: 22-29.
8. Stetler-Stevenson WH Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest. 1999 ; 103: 1237-1241.
9. Hashimoto G., Inoki I., Fujii Y., Aoki T., Ikeda E., Okada Y. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem. 2002 ; 277: 36288-36295.
10. Tokuraku M., Sato H., Murakami S., Okada Y., Watanabe Y., Seiki M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT1-MMP) and with lymph node metastasis. Int J Cancer. 1995 ; 64: 355-359.
11. Remacle AG, Noel A., Duggan C., et al. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Br J Cancer. 1998 ; 77: 926-931.
12. Theret N., Musso O., Campion J., et al. Overexpression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in liver from patients with gastrointestinal adenocarcinoma and no detectable metastasis. In J Cancer. 1997 ; 74: 426-432.
13. Tamakoshi K., Kikkawa F., Nawa A., McDermott E., O'Higgins N., Foidart JM Different pattern of zymography between human gynaecologic normal and malignant tissues. Am J Obstet Gynecol. 1994 ; 171: 478-484.
14. Ueno H., Yamashita K., Azumano I., Inoue M., Okada Y. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas Int J Cancer. 1999 ; 84: 470-477.
15. Liotta LA, Tryggvason K., Garbisa S., Hart I., Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980 ; 284: 67-71.
16. Fessler LI, Duncan KG, Fessler JH, Salo T., Tryggvason K. Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem. 1984 ; 259: 9783-9789.
17. Fahey MT, Irwig L., Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol. 1995 ; 141: 680-689.
18. Nasr M., Ayyad SB, El-Lamie IK, Mikhail MY Expression of matrix metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine cervix. Eur J Gynaecol Oncol. 2005 ; 26: 199-202.
19. Perello M., Friedman T., Paez-Espinosa V., Shen X., Stuart RC, Nillni EA Thyroid hormones selectively regulate the post-translational processing of prothyrotropin-releasing hormone in the paraventricular nucleus of the hypothalamus. Endocrinology. 2006 ; 147: 2705-2716.
20. Emond V., MacLaren LA, Kimmins S., Arosh JA, Fortier MA, Lambert RD Expression of cyclooxygenase-2 and granulocyte-macrophage colony-stimulating factor in the endometrial epithelium of the cow is up-regulated during early pregnancy and in response to intrauterine infusions of interferon-tau. Biol Reprod. 2004 ; 70: 54-64.
21. Sier CF, Zuidwijk K., Zijlmans HJ, et al. EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma. Int J Cancer. 2006 ; 118: 2991-2998.
22. Branca M., Ciotti M., Giorgi C., et al. Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN. Anticancer Res. 2006 ; 26: 1543-1556.
23. Levy A., Cioce V., Sobel ME, Garbisa S., Griogioni WF, Liotta LA Increased expression of the 72 kDa type IV collagenase in human colonic adenocarcinoma. Cancer Res. 1991 ; 51: 439-444.
24. Hoyhtya M., Fridman R., Komarek D., et al. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissue with monoclonal antibodies. Int J Cancer. 1994 ; 56: 500-505.
25. Monteagudo C., Merino MJ, SanJuan J, Liotta LA, Stetler Stevenson WJ. Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol. 1990 ; 136: 585-592.
26. Sheu BC, Lien HC, Ho HN, et al. Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res. 2003 ; 63: 6537-6542.
27. Liotta LA, Tryggvason K., Garbisa S., Hart I., Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980 ; 284: 67-68.
28. Nair AS, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai MR ras and c-myc oncoproteins during tumor progression in the uterine cervix. Tumori. 1998 ; 84: 583-588.
29. Väisänen A., Tuominen H., Kallioinen M., Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol. 1996 ; 180: 283-289.
30. Papadopoulou S., Scorilas A., Arnogianaki N., et al. Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa. Tumour Biol. 2001 ; 22: 383-389.
31. Brummer O., Athar S., Riethdorf L., Löning T., Herbst H. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study. Virchows Arch. 1999 ; 435: 566-573.
32. Gaiotto MA, Focchi J., Ribalta JL, et al. Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma. Am J Obstet Gynecol. 2004 ; 190: 1278-1282.
33. Jin JS, Hsieh DS, Lin YF, Wang JY, Sheu LF, Lee WH Increasing expression of extracellular matrix metalloproteinase inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters. Int J Urol. 2006 ; 13: 573-580.
34. Lam JS, Belldegrun AS, Figlin RA Tissue array-based predictions of pathobiology, prognosis and response to treatment for renal cell carcinoma therapy. Clin Cancer Res. 2004 ; 10: 6304-6309.
35. Hidalgo A., Piña P., Guerrero G., Lazos M., Salcedo M. A simple method for the construction of small format tissue arrays. J Clin Pathol. 2003 ; 56: 144-146.